DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: In peripheral blood monocytes (PBM) and myotubes of dysferlinopathy carriers bearing one mutation in DYSF, dysferlin expression is increased after vitamin D3 treatment [8].